Multi-drug resistant nephrotic syndrome (Q92377): Difference between revisions
From determinar.ia.br - Determine suas informações
Changed an Item |
Changed an Item |
||||||||||||||
| (4 intermediate revisions by the same user not shown) | |||||||||||||||
| Property / CURIE | |||||||||||||||
CID11:ID_22053390 | |||||||||||||||
| Property / CURIE: CID11:ID_22053390 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Canary Token | |||||||||||||||
dki-india-ID_22053390 | |||||||||||||||
| Property / Canary Token: dki-india-ID_22053390 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Verification Status | |||||||||||||||
Concluído | |||||||||||||||
| Property / Verification Status: Concluído / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Knowledge Architect | |||||||||||||||
| Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Collection date | |||||||||||||||
15 August 2026
| |||||||||||||||
| Property / Collection date: 15 August 2026 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Latest revision as of 07:31, 16 August 2026
This diagnosis refers to steroid resistant nephrotic syndrome where other immunosuppressive agents such as calcineurin inhibitors (cyclosporine, tacrolimus), mycophenolate and other immunosuppressive agents have been be trialled but have not resulted in remission. This entity can be due to many genetic, histological or other conditions. Reference: Nephrology WG Kidney Disease: Improving Global Outcomes (KDIGO) Glomerulonephritis Work Group. KDIGO Clinical Practice Guideline for Glomerulonephritis. Kidney inter., Suppl. 2012; 2: 139-274.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | ID_22053390 |
||
| English | Multi-drug resistant nephrotic syndrome |
This diagnosis refers to steroid resistant nephrotic syndrome where other immunosuppressive agents such as calcineurin inhibitors (cyclosporine, tacrolimus), mycophenolate and other immunosuppressive agents have been be trialled but have not resulted in remission. This entity can be due to many genetic, histological or other conditions. Reference: Nephrology WG Kidney Disease: Improving Global Outcomes (KDIGO) Glomerulonephritis Work Group. KDIGO Clinical Practice Guideline for Glomerulonephritis. Kidney inter., Suppl. 2012; 2: 139-274. |
Statements
CID11:ID_22053390
0 references
dki-india-ID_22053390
0 references
Concluído
0 references
15 August 2026
0 references
